Table 4.

Serum levels of TMAO before and after 4-week and 8-week treatment with Taurisolo® in study participants stratified for BMI.

	Baseline	t-4wk			t-8wk
	Mean ±SD	Mean ±SD	Δ% (vs. t0)	p (vs. t0)	Mean ±SD	Δ% (vs. t0)	p (vs. t0)
Normal weight (n = 57)	0.96 ± 0.61	0.48 ± 0.29	−50.27	<0.0001	0.33 ± 0.23	−65.53	<0.0001
Overweight (n = 21)	1.84 ± 0.59	1.30 ± 0.47	−29.27	<0.001	0.54 ± 0.29	−70.75	<0.0001
Grade I obesity (n = 16)	3.62 ± 0.88	2.04 ± 0.76	−43.68	<0.0001	0.72 ± 0.40	−80.12	<0.0001
Grade II obesity (n = 14)	7.06 ± 2.45	3.75 ± 0.73	−46.84	0.001	1.14 ± 1.00	−83.86	<0.0001

Statistical significance was calculated with Student's t-test; p < 0.05 was considered as significant.